| Evidence for HIV-associated B cell exhaustion in a dysfunctional memory B cell compartment in HIV-infected viremic individuals S Moir, J Ho, A Malaspina, W Wang, AC DiPoto, MA O'Shea, G Roby, ... The Journal of experimental medicine 205 (8), 1797-1805, 2008 | 969 | 2008 |
| Hepatitis C guidance: AASLD‐IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus AASLD/IDSA HCV Guidance Panel, RT Chung, GL Davis, DM Jensen, ... Hepatology 62 (3), 932-954, 2015 | 831 | 2015 |
| Infections Caused by Scedosporium spp KJ Cortez, E Roilides, F Quiroz-Telles, J Meletiadis, C Antachopoulos, ... Clinical microbiology reviews 21 (1), 157-197, 2008 | 795 | 2008 |
| HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells J Arthos, C Cicala, E Martinelli, K Macleod, D Van Ryk, D Wei, Z Xiao, ... Nature immunology 9 (3), 301-309, 2008 | 770 | 2008 |
| Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy TW Chun, DC Nickle, JS Justement, JH Meyers, G Roby, CW Hallahan, ... The Journal of infectious diseases 197 (5), 714-720, 2008 | 721 | 2008 |
| Chronic hepatitis B infection: a review LSY Tang, E Covert, E Wilson, S Kottilil Jama 319 (17), 1802-1813, 2018 | 674 | 2018 |
| Treatment of hepatitis C: a systematic review A Kohli, A Shaffer, A Sherman, S Kottilil Jama 312 (6), 631-640, 2014 | 634 | 2014 |
| Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates D Mavilio, J Benjamin, M Daucher, G Lombardo, S Kottilil, MA Planta, ... Proceedings of the National Academy of Sciences 100 (25), 15011-15016, 2003 | 479 | 2003 |
| NK cells in HIV infection: paradigm for protection or targets for ambush AS Fauci, D Mavilio, S Kottilil Nature Reviews Immunology 5 (11), 835-843, 2005 | 377 | 2005 |
| B cells in early and chronic HIV infection: evidence for preservation of immune function associated with early initiation of antiretroviral therapy S Moir, CM Buckner, J Ho, W Wang, J Chen, AJ Waldner, JG Posada, ... Blood, The Journal of the American Society of Hematology 116 (25), 5571-5579, 2010 | 309 | 2010 |
| Virologic response following combined ledipasvir and sofosbuvir administration in patients with HCV genotype 1 and HIV co-infection A Osinusi, K Townsend, A Kohli, A Nelson, C Seamon, EG Meissner, ... Jama 313 (12), 1232-1239, 2015 | 260 | 2015 |
| Expansion of treatment for hepatitis C virus infection by task shifting to community-based nonspecialist providers: a nonrandomized clinical trial S Kattakuzhy, C Gross, B Emmanuel, G Teferi, V Jenkins, R Silk, E Akoth, ... Annals of internal medicine 167 (5), 311-318, 2017 | 246 | 2017 |
| Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study A Kohli, R Kapoor, Z Sims, A Nelson, S Sidharthan, B Lam, R Silk, C Kotb, ... The Lancet Infectious Diseases 15 (9), 1049-1054, 2015 | 225 | 2015 |
| Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function S Kottilil, TW Chun, S Moir, S Liu, M McLaughlin, CW Hallahan, ... The Journal of infectious diseases 187 (7), 1038-1045, 2003 | 220 | 2003 |
| Virological response after 6 week triple-drug regimens for hepatitis C: a proof-of-concept phase 2A cohort study A Kohli, A Osinusi, Z Sims, A Nelson, EG Meissner, LL Barrett, D Bon, ... The Lancet 385 (9973), 1107-1113, 2015 | 181 | 2015 |
| Normalization of B cell counts and subpopulations after antiretroviral therapy in chronic HIV disease S Moir, A Malaspina, J Ho, W Wang, AC DiPoto, MA O'Shea, G Roby, ... The Journal of infectious diseases 197 (4), 572-579, 2008 | 180 | 2008 |
| Effect of sofosbuvir and ribavirin treatment on peripheral and hepatic lipid metabolism in chronic hepatitis C virus, genotype 1–infected patients EG Meissner, YJ Lee, A Osinusi, Z Sims, J Qin, D Sturdevant, ... Hepatology 61 (3), 790-801, 2015 | 166 | 2015 |
| Sofosbuvir and velpatasvir for the treatment of hepatitis C virus in patients coinfected with human immunodeficiency virus type 1: an open-label, phase 3 study D Wyles, N Bräu, S Kottilil, ES Daar, P Ruane, K Workowski, ... Clinical Infectious Diseases 65 (1), 6-12, 2017 | 157 | 2017 |
| Idiopathic CD4+ T lymphocytopenia is associated with increases in immature/transitional B cells and serum levels of IL-7 A Malaspina, S Moir, DG Chaitt, CA Rehm, S Kottilil, J Falloon, AS Fauci Blood 109 (5), 2086-2088, 2007 | 142 | 2007 |
| Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial DM Asmuth, RL Murphy, SL Rosenkranz, JJL Lertora, S Kottilil, Y Cramer, ... The Journal of infectious diseases 201 (11), 1686-1696, 2010 | 141 | 2010 |
